Neogen Chemicals Q1 Results: Earnings call recording released

1 min read     Updated on 27 Jul 2026, 08:41 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Neogen Chemicals Limited conducted an earnings conference call on July 27, 2026, discussing Q1FY27 results. The audio recording is available online per SEBI Regulation 30 compliance.

powered bylight_fuzz_icon
46710700

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals hosted an analysts and investors conference call on July 27, 2026, to discuss its financial results for the first quarter of fiscal year 2027. The management team used the session to address stakeholder queries regarding the company's operational and financial performance. The audio recording of this discussion is now publicly accessible on the company's official website, ensuring transparency for investors and market participants.

The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. Neogen Chemicals submitted the notification to both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on the same day. The filing confirms that the conference call took place at 4:00 p.m. on Monday, July 27, 2026.

Conference Call Details

The company has hosted the audio recording of the earnings call on its digital platform. Investors can access the file directly via the provided link on the Neogen Chemicals website. This step aligns with regulatory requirements for timely dissemination of material information to the investing public.

Detail Information
Event Analysts/Investors Conference Call
Date July 27, 2026
Time 4:00 p.m.
Regulation Regulation 30 of SEBI LODR 2015
Access Company Website

Regulatory Compliance

Unnati Kanani, Company Secretary and Compliance Officer of Neogen Chemicals, signed the disclosure letter. The document was digitally signed and timestamped on July 27, 2026, at 18:31:31 IST. The submission includes the company's scrip code on BSE (542665) and debt segment code (977028), as well as its symbol on NSE (NEOGEN).

What the Numbers Show

While the specific financial metrics were discussed during the call, the primary purpose of this filing is to provide access to the full transcript of management's commentary. Stakeholders are advised to review the audio recording for detailed insights into revenue trends, margin dynamics, and forward-looking guidance provided by the executive team during the session.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.06%-5.13%+6.18%+85.37%+28.73%+125.94%

How will the revenue trends and margin dynamics discussed in the Q1 FY27 call influence Neogen Chemicals' full-year earnings guidance?

What specific operational strategies did management outline to address potential supply chain disruptions or raw material cost volatility in the coming quarters?

Are there any new capacity expansion plans or capital expenditure projects announced that could impact future cash flows and debt levels?

Neogen Chemicals Q1 Results: Net profit rises 36% YoY to ₹19.44 crore

2 min read     Updated on 27 Jul 2026, 03:28 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Neogen Chemicals posted a 36.6% YoY rise in Q1FY26 net profit to ₹19.44 crore, with revenue jumping 36.7% to ₹252.28 crore. The Board approved a ₹600 crore fund raise and set August 13 as the dividend record date.

powered bylight_fuzz_icon
46691911

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals Limited reported a standalone net profit of ₹19.44 crore for the quarter ended June 30, 2026, marking a 36.6% year-on-year increase from ₹14.23 crore in Q1FY25. Revenue from operations rose 36.7% to ₹252.28 crore, up from ₹184.58 crore in the corresponding prior period, reflecting strong operational recovery following the March 2025 fire incident at its Dahej SEZ plant. Consolidated net profit grew 67.0% to ₹17.11 crore, while consolidated revenue increased 34.1% to ₹250.29 crore.

The Board of Directors, meeting on July 24, 2026, approved the unaudited financial results reviewed by statutory auditors Chandabhoy & Jassoobhoy. Management also granted in-principle approval to raise funds of up to ₹600 crore through equity shares, qualified institutional placements (QIP), or other eligible securities, subject to shareholder and regulatory approvals. Additionally, the Board appointed CNK & Associates as the internal auditor for FY2026-27 and scheduled the 37th Annual General Meeting for August 21, 2026.

Financial Performance

Standalone operating margins expanded to 19.09% from 17.68% in FY25, while net profit margins improved to 7.70% from 5.49%. Finance costs rose to ₹23.10 crore from ₹14.03 crore year-on-year, partly offset by higher revenue growth. Consolidated EBITDA margins stood at 19.35%, compared to 15.96% in FY25. The company’s debt-equity ratio improved to 0.68 times from 0.79 times at the end of FY25, indicating a strengthening balance sheet.

Metric Q1FY26 (₹ Cr) Q1FY25 (₹ Cr) Change
Revenue from Operations 252.28 184.58 +36.7%
Net Profit (Standalone) 19.44 14.23 +36.6%
Net Profit (Consolidated) 17.11 10.26 +67.0%
Operating Margin (%) 19.09% 17.68% +141 bps

Insurance Claim Recovery

The company continues to recover from the fire incident on March 5, 2025, which caused a recognized loss of ₹348.16 crore. As of June 30, 2026, Neogen Chemicals had received ₹140.00 crore as on-account payments and realized ₹9.38 crore from scrap sales. An additional ₹15.00 crore was received post-quarter-end, reducing the outstanding insurance claim receivable to ₹186.63 crore. Management maintains that the remaining claim is fully recoverable.

Capital Raise and Shareholder Updates

The Board’s in-principle approval for a ₹600 crore fund raise allows flexibility in instrument choice, including equity and debt, to support future growth initiatives. The record date for determining eligibility for remote e-voting and the final dividend for FY25 is set for August 13, 2026. The Register of Members will remain closed from August 14, 2026, to August 21, 2026. Crisil Ratings Limited downgraded the company’s long-term rating to 'Crisil A-/Negative' from 'Crisil A/Negative' on July 17, 2026, leading to a coupon rate increase on its ₹200 crore NCDs from 10.50% to 11.00% per annum.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.06%-5.13%+6.18%+85.37%+28.73%+125.94%

How will the ₹600 crore capital raise be allocated between debt reduction and growth initiatives, and what impact will this have on the company's leverage ratio?

What specific operational strategies is Neogen Chemicals implementing to sustain the expanded operating margins of 19.09% amid potential raw material price volatility?

Given the Crisil rating downgrade and the 50 bps increase in NCD coupon rates, how might this affect the company's cost of capital for future borrowing?

More News on Neogen Chemicals

1 Year Returns:+28.73%